Zhejiang Huahai Pharmaceutical Co. Ltd. | Ownership
Companies that own Zhejiang Huahai Pharmaceutical Co. Ltd.
Fullgoal Fund Management Co., Ltd.
19,479,252
1.58%
6,214,878
0.55%
12/31/2017
Norges Bank Investment Management
16,496,294
1.34%
16,496,294
0.01%
03/31/2018
China Investment Corp. (Investment Management)
15,305,290
1.24%
-3,061,058
0.13%
03/31/2018
Taikang Asset Management Co., Ltd.
13,811,665
1.12%
941,927
0.93%
03/31/2018
Penghua Fund Management Co., Ltd.
10,261,019
0.83%
-3,766,101
0.31%
03/31/2018
Haitong Securities Asset Management Co., Ltd.
10,097,969
0.82%
-3,001,115
13.76%
03/31/2018
Huatai-PineBridge Fund Management Co., Ltd.
9,151,462
0.74%
9,060,657
0.54%
12/31/2017
China Asset Management Co., Ltd.
9,037,251
0.73%
-2,556,964
0.13%
12/31/2017
China Foreign Economy & Trade Trust Co., Ltd.
8,501,296
0.69%
8,501,296
2.79%
03/31/2018
Lion Fund Management Co., Ltd.
6,872,843
0.56%
-1,725,979
0.96%
12/31/2017
| Address |
Xunqiao Town
Linhai Zhejiang 317024
China
|
|
Employees
|
- |
| Website |
http://www.huahaipharm.com |
| Updated |
07/08/2019 |
| Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. |
